跳至主要内容
临床试验/JPRN-UMIN000049260
JPRN-UMIN000049260已完成Unknown

Skin clarity evaluation test by using the test product for 8 weeks - Skin clarity enhancement test

DRC CO., LTD.0 个研究点目标入组 25 人开始时间: 2023年5月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
DRC CO., LTD.
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 60years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • (1)Those with red faces (2) Those who have either excessive rough skin, many fine freckle-like spots, or large, dark spots on the skin in the third position. (3) Any skin conditions (urticaria, inflammation, eczema, trauma, acne, pimples, warts, etc., or traces of such conditions) that may affect the results of the study on the skin of the evaluation site. (4) Patients with a history or current history of atopic dermatitis or with a predisposition to atopic dermatitis. (5) Applicants who have undergone or will undergo cosmetic treatment (Botox injections, hyaluronic acid or collagen injections, photofacials, etc.) on the evaluation site during the examination period. (6) Have undergone or are scheduled to undergo special skin care procedures (beauty salons, esthetic clinics, etc.) on the evaluation site within the past 4 weeks. (7) The applicant uses quasi-drug lotions, milky lotions, creams, all-in-one products, serums, and packs as daily skin care products for the evaluation site. (8) Those who use basic skin care products containing vitamin C or health foods containing vitamin C on a regular basis as daily skin care for the evaluated area. (9) The subject continuously uses skincare products, cosmetics, quasi-drugs, or health food products that claim or emphasize efficacy (prevention and improvement of age spots, whitening effect) similar to or related to the efficacy studied in this study on the evaluated area. (10) Exposure to ultraviolet radiation beyond daily activities such as prolonged outdoor work, exercise, swimming, leisure activities, etc., within the past 4 weeks or plans to do so during the study period (e.g., golf, fishing, etc.). (11) Patients who are undergoing treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at a medical institution for the treatment or prevention of disease, or whose condition is judged to be in need of treatment at the time of obtaining consent. -and other

研究者

发起方
DRC CO., LTD.

相似试验